Condition: Foot Ulcer Due to Type 2 Diabetes Mellitus · Sponsor: Ole Lander Svendsen
The aim of this exploratory pilot study is to investigate the effect of semaglutide compared to placebo on healing of foot ulcers in type 2 diabetes patients. It is a randomized double blind, placebo controlled, clinical intervention study of 20 weeks intervention.
This description comes directly from the study's public registry record.
Ole L Svendsen, MD · +45 21830863 · ole.lander.svendsen@regionh.dk
klaus Kirketerp-Møller, MD · +4538635134 · klaus.kirketerp-moeller.01@regionh.dk
Always discuss trial participation with your own doctor first.
| Copenhagen Wound Healing Center, Bispebjerg University Hospital | Copenhagen, Denmark | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07581145